Nipradilol
![]() | |
Names | |
---|---|
IUPAC name [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C15H22N2O6 | |
Molar mass | 326.349 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Chemical compound
Nipradilol is a beta blocker and nitric oxide donor.[1]
References
[edit]- ^ Inoue, K; Kei Noguchi, K; Masumoto, M; Wakakura, G (2011). "Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma". Clinical Ophthalmology. 5: 1211–6. doi:10.2147/OPTH.S23233. PMC 3180485. PMID 21966188.
Forms | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Targets |
| ||||||||||||||
NO donors (prodrugs) |
| ||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators |
![]() | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |